Related references
Note: Only part of the references are listed.Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease
Li Ou et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Added value of plasma metabolomics to describe maternal effects in rat maternal and prenatal toxicity studies
J. Keller et al.
TOXICOLOGY LETTERS (2019)
An integrative investigation on the efficacy of Plantaginis semen based on UPLC-QTOF-MS metabolomics approach in hyperlipidemic mice
Xiaomeng Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity
Yvonne Gloor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Mechanisms of bergenin treatment on chronic bronchitis analyzed by liquid chromatography-tandem mass spectrometry based on metabolomics
Caijuan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?
Ilaria Motta et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Assessment of hepatotoxicity of first-line anti-tuberculosis drugs on Wistar rats
Radhika Sharma et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform
Jun Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
Romeo Papazyan et al.
JOURNAL OF LIPID RESEARCH (2018)
Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease
Qinwei Yu et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Metabolomics profiling of steatosis progression in HepaRG ® cells using sodium valproate
Matthias Cuykx et al.
TOXICOLOGY LETTERS (2018)
Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study
Ndivhuho A. Makhado et al.
LANCET INFECTIOUS DISEASES (2018)
Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis
Albert Dompreh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response
Weiping Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice
Ju-Hyun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids
Tingting Yang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach
He Zhao et al.
TOXICOLOGY RESEARCH (2017)
Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise
Marcus Moberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage
J. E. Edwards et al.
CTS-Clinical and Translational Science (2016)
Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway
Yun Zhang et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki et al.
PLOS ONE (2016)
15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome
Naresh Kumar et al.
SCIENTIFIC REPORTS (2016)
First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
Omaima El Bouazzi et al.
PAN AFRICAN MEDICAL JOURNAL (2016)
Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity
Ru Chen et al.
ARCHIVES OF TOXICOLOGY (2015)
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brian C. Ferslew et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
Johannes Schmitt et al.
LIVER INTERNATIONAL (2015)
Detection of Anti-Isoniazid and Anti-Cytochrome P450 Antibodies in Patients With Isoniazid-Induced Liver Failure
Imir G. Metushi et al.
HEPATOLOGY (2014)
Isoniazid Hepatotoxicity: Progress in Understanding the Immunologic Component
Laura James et al.
HEPATOLOGY (2014)
Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing
Adam J. Shuhendler et al.
NATURE BIOTECHNOLOGY (2014)
Evaluation of Serum Bile Acid Profiles as Biomarkers of Liver Injury in Rodents
Lina Luo et al.
TOXICOLOGICAL SCIENCES (2014)
Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement
Sherry Joseph Martin et al.
TOXICOLOGY MECHANISMS AND METHODS (2014)
Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity
Tung-Yuan Shih et al.
AAPS JOURNAL (2013)
A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide
Tung-Yuan Shih et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Hypoxic liver injury and cholestasis in critically ill patients
Thomas Horvatits et al.
CURRENT OPINION IN CRITICAL CARE (2013)
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy
Feng Li et al.
NATURE MEDICINE (2013)
Metabolomic Signatures in Guinea Pigs Infected with Epidemic-Associated W-Beijing Strains of Mycobacterium tuberculosis
Bagganahalli S. Somashekar et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide
Jiye Aa et al.
METABOLOMICS (2011)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Role of oxidative stress and nitric oxide in the protective effects of α-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats
Evan I. Saad et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations. Part 1: First-line drugs
Marcos Abdo Arbex et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2010)
Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats
Jiang Yue et al.
PHARMACOLOGICAL RESEARCH (2009)
Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures
C. Shen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cytochrome p450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis
YS Huang et al.
HEPATOLOGY (2003)
Share Paper
